Security key
03969K108
Arcutis Biotherapeutics, Inc. - COMMON STOCK (ARQT)
CUSIP: 03969K108
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 128,710,441
- Total 13F value
- $1,792,934,402
- Share change
- +22,308
- Put/Call ratio
- 45%
- SEC-reported price per share
- $13.93
- Number of holders
- 206
- Value change
- +$13,789,213
- Number of buys
- 97
- Number of sells
- 93
- Shares outstanding
- 126,534,885
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
206
Top holders
10
ARQT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
Arcutis Biotherapeutics, Inc. SEC filings
Arcutis Biotherapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03969K108
Recent filing periods:
Ownership snapshot
Top reported holders of ARQT - Arcutis Biotherapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Frazier Life Sciences VII...
Disclosed value leader
JENNISON ASSOCIATES LLC
Comparable rows
0/15
Latest evidence
30 Sep 2024
3/4/5
13F
Highest disclosed value: $108,470,523
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
JENNISON ASSOCIATES LLC has the largest disclosed position value at $108.47M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens JENNISON ASSOCIATES LLC's linked filing trail.
Disclosed position value
Top 5
Frazier Life Sciences VIII, L.P.
$31.26M
ORBIMED ADVISORS LLC
$1.47M
JENNISON ASSOCIATES LLC
$108.47M
Rubric Capital Management LP
$101.99M
MONTANOVA CAPITAL, LLC
$99.71M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Frazier Life Sciences VIII, L.P. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$31,255,566
8,827,261 shares
|
— | 24 Oct 2023 |
| ORBIMED ADVISORS LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$1,469,935
415,142 shares
|
— | 24 Jun 2022 |
| JENNISON ASSOCIATES LLC |
13F
Company
|
—
denominator unverified
|
$108,470,523
11,663,497 shares
|
— | 30 Sep 2024 |
| Rubric Capital Management LP |
13F
Company
|
—
denominator unverified
|
$101,990,050
10,966,672 shares
|
— | 30 Sep 2024 |
| MONTANOVA CAPITAL, LLC |
13F
Company
|
—
denominator unverified
|
$99,710,052
10,721,511 shares
|
— | 30 Sep 2024 |
| BlackRock, Inc. |
13F
Company
|
—
denominator unverified
|
$83,974,869
9,029,556 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
206
Shares
128,710,441
Rows available
206
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
187
Q4 2024 holders
206
Holder diff
19
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend